Edwards Lifesciences

Open: 92.9 Close: 92.65 Change: -0.25

Don't invest before reading what an AI found about Edwards Lifesciences.

The game is changing. There is a new strategy to evaluate Edwards Lifesciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Edwards Lifesciences are: Edwards, Lifesciences, structural, heart, disease, critical, care, …

Concept Map

Semantic Network

Stock Summary

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, critical care and surgical monitoring. It offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name. The company distributes.

Today's Summary

Edwards Lifesciences expects the global TAVR opportunity to increase to $10 billion by 2028. The company employs over 13,000 individuals worldwide.

Today's News

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, critical care and surgical monitoring in the United States. Edwards Lifesciences (NYSE:EW) saw a significant share price rise of over 20% in the past couple of months. Edwards Lifsciences expects the global TAVR opportunity to increase to $10 billion by 2028. Edwards Lifesciences Corp (EW) stock is down -0.65% while the S&P 500 is up 0.51% as of 3:35 PM on Monday, Jul 17. Edwards Lifsciences has a market capitalization of $55.84 billion. Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Headquartered in Irvine, California, the company employs over 13,000 individuals worldwide.

Stock Profile

"Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California."

Keywords

Are looking for the most relevant information about Edwards Lifesciences? Investor spend a lot of time searching for information to make investment decisions in Edwards Lifesciences. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Edwards Lifesciences are: Edwards, Lifesciences, structural, heart, disease, critical, care, and the most common words in the summary are: edward, lifesciences, stock, zacks, pub, ew, earnings, . One of the sentences in the summary was: Edwards Lifesciences expects the global TAVR opportunity to increase to $10 billion by 2028. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #edward #lifesciences #stock #zacks #pub #ew #earnings.